medigraphic.com
Anales de Otorrinolaringología Mexicana

2022, Number 2

Next >>

Otorrinolaringología 2022; 67 (2)

Risk associated with surgical reintervention with dilations in laryngotracheal stenosis

Intriago-Alor M, Romero-Gameros CA, García-Cobarruvias L, Angulo-Pérez G

Language: Spanish
References: 12
Page: 115-122
PDF size: 312.54 Kb.


ABSTRACT

Objective: To measure the association of the presence of comorbidities with the risk of reoperation and the degree of severity of the stenosis.
Materials and Methods: Cross-sectional, observational, retrospective, analytical study that included patients with a diagnosis of laryngotracheal stenosis who underwent mechanical tracheal dilations from January 2015 to December 2019. The data were collected by reviewing the patients’ clinical records. A stratified analysis was performed to evaluate the association of comorbidities with the risk of surgical reintervention and degree of severity of stenosis.
Results: There were included 60 patients, we found a higher prevalence of tracheal stenosis in males (n = 33); the most frequent comorbidity was overweight, followed by systemic arterial hypertension and type 2 diabetes mellitus. No statistically significant association was observed between comorbidities and risk of reoperation in the stratified analysis; however, it was observed that type 2 diabetes mellitus obtained an OR of 3.59 (95% CI: 1.01-13.61) for a degree of stenosis of 51-70% and rheumatological diseases an OR of 9.73 (95% CI: 1.12-4.47).
Conclusions: Diabetes mellitus and rheumatological diseases are risk factors of stenosis with a greater degree of severity.


REFERENCES

  1. Schweiger C. Incidence of post-intubation subglottic stenosisin children: prospective study. J Laryngol Otol 2013;127: 399-403. doi: 10.1017/S002221511300025X.

  2. McCaffrey TV. Laryngotracheal stenosis. Lippincott Williams& Wilkins; 2003; 244.

  3. Romero ME, Patiño GC, Ravetta P, Defago V, Tessi C Dilationwith rigid dilators as primary treatment of subglotticstenosis in pediatrics. J Pulmonol 2020. https://doi.org/10.1016/j.pulmoe.2020.03.007.

  4. Ettema SL, Loerhl TA, Toohill RJ, Merati AL. The prevalenceof diabetes in a series of patients with subglottic stenosis.Ear Nose Throat J 2007; 86 (11): 687-90.

  5. Sinacori JT, Taliercio SJ, Duong E, Benson C. Modalitiesof treatment for laryngotracheal stenosis: The EVMS experience.Laryngoscope 2013; 123 (12): 3131-3136. doi:10.1002/ lary.24237.

  6. Nicolli, E. Risk factors for adult acquired subglotticstenosis. J Laryngol Otol 2017: 264-267, doi:10.1017/S0022215116009798.

  7. Feinstein A, Goel A, Raghavan G, Long J, et al. Endoscopicmanagement of subglottic stenosis. JAMA OtolaryngolHead Neck Surg 2017; 143 (5): 500-505. doi: 10.1001/jamaoto.2016.4131.

  8. Sol Kil Oh, Ki Nam Park, Seung Won Lee. Long-term resultsof endoscopic dilatation for tracheal and subglottic stenosisrisk factors for adult acquired subglottic stenosis. ClinExperiment Otorhinolaryngol 2014; 7 (4): 324-328. https://doi.org/10.3342/ceo.2014.7.4.324.

  9. Dablanca M, Maeso A, Méndez D, Ortega P. Estenosis laringotraquealesde etiología autoinmune. Acta OtorrinolaringolEsp 2017; 68 (1): 38-42. DOI: 10.1016/j.otorri.2016.01.002.

  10. Schokkenbroek A, Franssen C, Dikkers F. Dilatation tracheoscopyfor laryngeal and tracheal stenosis in patientswith Wegener’s granulomatosis. Eur Arch Otorhinolaryngol2008; 265: 549- 555. doi: 10.1007/s00405-007-0518-3.

  11. Gelbard, A. Comparative treatment outcomes for patientswith idiopathic subglottic stenosis. JAMA OtolaryngolHead Neck Surg 2020; 146 (1): 20-29. doi:10.1001/jamaoto.2019.3022.

  12. Horta G, Hernández MF, Catana R, Pérez M, Barile LA.Estenosis subglótica en granulomatosis con poliangitis(granulomatosis de Wegener): presentación de 4 casos.Reumatol Clin 2016; 12 (5): 267-273. DOI: 10.1016/j.reuma.2015.10.009.




2020     |     www.medigraphic.com